- Virtus Investment Partners recently converted the Zevenbergen Growth and Zevenbergen Genea mutual funds into the actively managed Virtus Zevenbergen Innovative Growth ETF (ZINN) and Virtus Zevenbergen Discovery Growth ETF (ZDIS), expanding its lineup of growth-focused exchange-traded products.
- This move deepens Virtus’ presence in active ETFs while giving investors access to Zevenbergen Capital Investments’ concentrated, high-growth equity approach in a more flexible and transparent vehicle.
- We’ll now examine how expanding Virtus’ actively managed ETF lineup through these mutual fund conversions influences the company’s broader investment narrative.
Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
What Is Virtus Investment Partners' Investment Narrative?
To own Virtus, you really have to believe in its ability to steadily monetize its multi-boutique platform even as revenue has slipped recently and the share price has lagged both the market and peers. The latest ETF conversions with Zevenbergen and the launch of other active ETFs add incremental product breadth, but with only around US$208 million of assets shifting into ZINN and ZDIS, the near term earnings impact looks modest. More meaningful in the short run are capital allocation choices: a higher quarterly dividend of US$2.45 per share and ongoing buybacks, both of which matter when free cash flow coverage already looks tight. The appointment of distribution veteran Jack Boyce to the board slightly tilts the catalyst mix toward execution on growth products, but it does not remove the core risk that fee pressure and muted organic growth could keep returns subdued.
However, the dividend coverage question is something investors should be aware of. Virtus Investment Partners' shares have been on the rise but are still potentially undervalued by 30%. Find out what it's worth.Exploring Other Perspectives
Two Simply Wall St Community fair values for Virtus span roughly US$148 to about US$237, underlining how far apart individual views can be. When you set that against weak recent earnings trends and concerns over dividend coverage, it becomes clear why many investors may want to compare several of these community perspectives before deciding how much weight to place on Virtus’ current performance profile.
Explore 2 other fair value estimates on Virtus Investment Partners - why the stock might be worth 12% less than the current price!
Reach Your Own Conclusion
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Virtus Investment Partners research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
- Our free Virtus Investment Partners research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Virtus Investment Partners' overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
- Uncover the next big thing with 23 elite penny stocks that balance risk and reward.
- Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
- Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com